Data / Drug companies / For suspension
Companies that list for suspension products: 38 companies and 83 products in the FDA NDC directory
The FDA National Drug Code Directory lists 83 products that are for suspension products from 38 companies. The ten largest listers hold 57.8% of them, and the newest started marketing on October 9, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 38
- Products
- 83
- Drugs by generic name
- 22
- Main marketing category
- Generic drugs (ANDA)
Companies that list for suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 7 | for suspension | Generic drugs (ANDA) | April 1, 2024 |
| Bryant Ranch Prepack | 6 | for suspension | Generic drugs (ANDA) | March 28, 2019 |
| A-S Medication Solutions | 5 | for suspension | Generic drugs (ANDA) | March 28, 2019 |
| Ajanta Pharma USA Inc. | 5 | for suspension | Generic drugs (ANDA) | February 9, 2023 |
| Cipla USA Inc. | 5 | for suspension | Generic drugs (ANDA) | January 7, 2025 |
| Preferred Pharmaceuticals Inc. | 5 | for suspension | Generic drugs (ANDA) | June 3, 2024 |
| USAntibiotics, LLC | 5 | for suspension | Authorized generics (NDA) | April 1, 2024 |
| Bryant Ranch Prepack | 4 | for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Bryant Ranch Prepack | 3 | for suspension | Generic drugs (ANDA) | March 28, 2019 |
| Lupin Pharmaceuticals, Inc. | 3 | for suspension | Generic drugs (ANDA) | September 6, 2017 |
| Ascend Laboratories, LLC | 2 | for suspension | Generic drugs (ANDA) | March 28, 2019 |
| Cadila Pharmaceuticals Limited | 2 | for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Harrow Eye, LLC | 2 | for suspension | New drug applications (NDA) | April 7, 2025 |
| Kanchan Healthcare Inc | 2 | for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Remedyrepack Inc. | 2 | for suspension | Authorized generics (NDA) | December 2, 2025 |
| Sandoz Inc | 2 | for suspension | Generic drugs (ANDA) | September 4, 2007 |
| Strides Pharma Science Limited | 2 | for suspension | Generic drugs (ANDA) | February 2, 2024 |
| Alembic Pharmaceuticals Inc. | 1 | for suspension | Generic drugs (ANDA) | June 29, 2026 |
| Alembic Pharmaceuticals Limited | 1 | for suspension | Generic drugs (ANDA) | June 29, 2026 |
| Allegis Holdings, LLC | 1 | for suspension | New drug applications (NDA) | September 1, 2023 |
| American Health Packaging | 1 | for suspension | Generic drugs (ANDA) | August 1, 2023 |
| Amneal Pharmaceuticals NY LLC | 1 | for suspension | Generic drugs (ANDA) | March 5, 2018 |
| Amneal Pharmaceuticals of New York LLC | 1 | for suspension | Generic drugs (ANDA) | January 20, 2023 |
| Ani Pharmaceuticals, Inc. | 1 | for suspension | Generic drugs (ANDA) | May 31, 2019 |
| Asclemed USA Inc. | 1 | for suspension | Authorized generics (NDA) | April 1, 2024 |
| AvKARE | 1 | for suspension | Generic drugs (ANDA) | August 26, 2019 |
| Camber Pharmaceuticals, Inc. | 1 | for suspension | Generic drugs (ANDA) | May 11, 2021 |
| Dr. Reddy's Laboratories Inc. | 1 | for suspension | Generic drugs (ANDA) | March 15, 2024 |
| Exelan Pharmaceuticals Inc. | 1 | for suspension | Generic drugs (ANDA) | December 1, 2023 |
| La Jolla Pharmaceutical Company | 1 | for suspension | New drug applications (NDA) | October 9, 2026 |
| Lupin Pharmaceuticals, Inc. | 1 | for suspension | Generic drugs (ANDA) | September 29, 2025 |
| Lupin Pharmaceuticals,Inc. | 1 | for suspension | Generic drugs (ANDA) | December 17, 2012 |
| Macleods Pharmaceuticals Limited | 1 | for suspension | Generic drugs (ANDA) | July 11, 2025 |
| Proficient Rx LP | 1 | for suspension | Generic drugs (ANDA) | September 6, 2017 |
| Redpharm Drug | 1 | for suspension | Authorized generics (NDA) | September 19, 2022 |
| Somerset Therapeutics, LLC | 1 | for suspension | Generic drugs (ANDA) | February 26, 2025 |
| Virtus Pharmaceuticals, LLC | 1 | for suspension | Generic drugs (ANDA) | August 2, 2021 |
| Zydus Pharmaceuticals USA Inc. | 1 | for suspension | Generic drugs (ANDA) | September 14, 2017 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Famotidine | 3 | 138 |
| Esomeprazole magnesium | 4 | 77 |
| Doxycycline | 1 | 63 |
| Pantoprazole sodium | 2 | 54 |
| Sildenafil | 1 | 53 |
| Oxcarbazepine | 1 | 46 |
| Dexamethasone | 1 | 45 |
| Clobetasol propionate | 1 | 40 |
| Oseltamivir phosphate | 11 | 37 |
| Cephalexin | 28 | 36 |
| Amoxicillin and clavulanate potassium | 7 | 35 |
| Amoxicillin | 4 | 35 |
| Sevelamer carbonate | 2 | 35 |
| Nitrofurantoin | 1 | 28 |
| Clarithromycin | 3 | 27 |
| Sildenafil citrate | 1 | 24 |
| Colesevelam hydrochloride | 1 | 12 |
| Omeprazole and sodium bicarbonate | 2 | 11 |
| Erythromycin ethylsuccinate | 6 | 8 |
| Rivaroxaban granule | 1 | 1 |
| Sildenafil powder, | 1 | 1 |
| Zoliflodacin | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.